• 대한생식의학회:학술대회논문집
• /
• 1996.11a
• /
• pp.68-69
• /
• 1996

• 대한핵의학회:학술대회논문집
• /
• 1992.06a
• /
• pp.181.2-181.2
• /
• 1992

• 대한임상약리학회:학술대회논문집
• /
• 2001.06a
• /
• pp.9-10
• /
• 2001

• 대한핵의학회:학술대회논문집
• /
• 1987.05a
• /
• pp.131.1-131.1
• /
• 1987

• Clinical and Experimental Pediatrics
• /
• v.64 no.2
• /
• pp.93-95
• /
• 2021

• Women's Health Nursing
• /
• v.25 no.2
• /
• pp.232-233
• /
• 2019

• Proceedings of the Korean Society of Medical Physics Conference
• /
• 2006.08a
• /
• pp.77-77
• /
• 2006

• Korean Journal of Radiology
• /
• v.23 no.11
• /
• pp.1089-1101
• /
• 2022

Immunotherapy has revolutionized and opened a new paradigm for cancer treatment. In the era of immunotherapy and molecular targeted therapy, precision medicine has gained emphasis, and an early response assessment is a key element of this approach. Treatment response assessment for immunotherapy is challenging for radiologists because of the rapid development of immunotherapeutic agents, from immune checkpoint inhibitors to chimeric antigen receptor-T cells, with which many radiologists may not be familiar, and the atypical responses to therapy, such as pseudoprogression and hyperprogression. Therefore, new response assessment methods such as immune response assessment, functional/molecular imaging biomarkers, and artificial intelligence (including radiomics and machine learning approaches) have been developed and investigated. Radiologists should be aware of recent trends in immunotherapy development and new response assessment methods.

• Proceedings of the Korean Society of Medical Physics Conference
• /
• 2006.08a
• /
• pp.57-57
• /
• 2006

• Proceedings of the Korean Society of Medical Physics Conference
• /
• 1999.11a
• /
• pp.390-391
• /
• 1999